Sp651

DEBATE: LIFE LONG FOOD ELIMINATION - SIX FOOD ELIMINATION IS THE BEST OPTION

Date
May 19, 2024

Presenter

Speaker Image for Nirmala Gonsalves
Northwestern University - The Feinberg School of Medicine

Tracks

Related Products

Thumbnail for <i>THE SEVERITY OF REDUCED ESOPHAGEAL DISTENSIBILITY PARALLELS EOSINOPHILIC DISEASE DURATION</i>
<i>THE SEVERITY OF REDUCED ESOPHAGEAL DISTENSIBILITY PARALLELS EOSINOPHILIC DISEASE DURATION</i>
Concomitant esophageal dysmotility can be present in up to 2/3 of patients with EoE and GERD. Esophageal dysmotility contribute to symptoms in these patients and can be a reason for a suboptimal response to therapy…
Thumbnail for SMALL GROUP DISCUSSIONS IN ROOM
SMALL GROUP DISCUSSIONS IN ROOM
This 90 minute session is designed to link junior faculty/GI fellows/other trainees who are interested in pursuing a clinical/research career in diseases of the upper gastrointestinal tract with established clinician/researcher experts in the field…
Thumbnail for EOSINOPHILIC ESOPHAGITIS
EOSINOPHILIC ESOPHAGITIS
This 90 minute session is designed to link junior faculty/GI fellows/other trainees who are interested in pursuing a clinical/research career in diseases of the upper gastrointestinal tract with established clinician/researcher experts in the field…
Thumbnail for LONGITUDINAL EFFECTS OF TREATMENT ON ESOPHAGEAL DYSMOTILITY IN EOSINOPHILIC ESOPHAGITIS
LONGITUDINAL EFFECTS OF TREATMENT ON ESOPHAGEAL DYSMOTILITY IN EOSINOPHILIC ESOPHAGITIS
BACKGROUND: Novel treatment options for eosinophilic esophagitis (EoE) are needed. Previous studies have assessed mepolizumab (mepo), a monoclonal antibody against IL-5, with mixed results in EoE, and the efficacy of mepo in an adult and adolescent population has yet to be fully examined…